Jascayd (nerandomilast) Live Broadcast Event: Interstitial Lung Disease
Spurrier's Gridiron Grille
4860 Steve Spurrier Way
Gainesville, FL 32608
Thursday, February 26, 2026 at 6:30pm ET - 8:00pm ET
Info
Topic
Jascayd: Interstitial Lung Disease
Attachments
Jascayd
(2.1 MB)
Additional Information
Jascayd-oral med selective PDE4 inhibitor approved for treatment of adults diagnosed with Idiopathic Pulmonary Fibrosis and Progressive Pulmonary Fibrosis.
*Registration restricted to Medical providers in current practice.
RSVP: 877.925.9550
Speakers
Toby Maher
MD, PhD
University of Southern California
Elizabeth Volkmann
MD, MS
University of California, Los Angeles, CA
Interested In Attending This Event?
Additional Registration Information:
Register via email or phone 887.925.9550 with name/license number.
*Registration restricted to medical providers in current practice.